A Randomized Controlled Study To Assess Safety, Tolerability And Efficacy Of PSI-7977 In Combination With Full or Low Dose RBV In HCV Genotype 1, Monoinfected Treatment Naive Participants.

Trial Profile

A Randomized Controlled Study To Assess Safety, Tolerability And Efficacy Of PSI-7977 In Combination With Full or Low Dose RBV In HCV Genotype 1, Monoinfected Treatment Naive Participants.

Completed
Phase of Trial: Phase I/II

Latest Information Update: 17 Apr 2016

At a glance

  • Drugs Sofosbuvir (Primary) ; Ribavirin
  • Indications Hepatitis C
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms SPARE
  • Most Recent Events

    • 17 Apr 2016 Results assessing Sofosbuvir-based therapy among patients with mental health disease from SPARE, SYNERGY-A and ERADICATE studies, spresented at The International Liver Congress™ 2016.
    • 25 Sep 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 14 Mar 2014 Planned End Date changed from 1 Aug 2013 to 1 Apr 2014 as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top